- Home
- CMPO vs TARS Comparison
CMPO vs TARS Comparison
Compare CMPO & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPO
- TARS
- Stock Information
- Founded
- CMPO 2000
- TARS 2016
- Country
- CMPO United States
- TARS United States
- Employees
- CMPO N/A
- TARS N/A
- Industry
- CMPO Finance: Consumer Services
- TARS Medicinal Chemicals and Botanical Products
- Sector
- CMPO Finance
- TARS Health Care
- Exchange
- CMPO Nasdaq
- TARS Nasdaq
- Market Cap
- CMPO 1.5B
- TARS 1.8B
- IPO Year
- CMPO N/A
- TARS 2020
- Fundamental
- Price
- CMPO $16.25
- TARS $54.44
- Analyst Decision
- CMPO Strong Buy
- TARS Strong Buy
- Analyst Count
- CMPO 7
- TARS 5
- Target Price
- CMPO $16.36
- TARS $54.20
- AVG Volume (30 Days)
- CMPO 753.3K
- TARS 469.2K
- Earning Date
- CMPO 11-08-2024
- TARS 11-13-2024
- Dividend Yield
- CMPO N/A
- TARS N/A
- EPS Growth
- CMPO N/A
- TARS N/A
- EPS
- CMPO N/A
- TARS N/A
- Revenue
- CMPO $419,612,000.00
- TARS $129,621,000.00
- Revenue This Year
- CMPO $10.30
- TARS $895.24
- Revenue Next Year
- CMPO $6.26
- TARS $73.78
- P/E Ratio
- CMPO N/A
- TARS N/A
- Revenue Growth
- CMPO 9.13
- TARS 801.96
- 52 Week Low
- CMPO $4.61
- TARS $18.84
- 52 Week High
- CMPO $17.03
- TARS $54.44
- Technical
- Relative Strength Index (RSI)
- CMPO 58.62
- TARS 66.99
- Support Level
- CMPO $15.92
- TARS $51.08
- Resistance Level
- CMPO $17.03
- TARS $53.85
- Average True Range (ATR)
- CMPO 0.56
- TARS 2.41
- MACD
- CMPO -0.03
- TARS -0.05
- Stochastic Oscillator
- CMPO 56.45
- TARS 90.70
About CMPO CompoSecure Inc.
CompoSecure Inc is engaged in designing and manufacturing premium financial cards. The Company's metal payment card technology and Arculus security and authentication capabilities deliver premium branded experiences which enable people to access and use their assets, and ensure trust at the point of a transaction. Its products include Metal Cards and Arculus, a digital security platform.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.